1.Idiopathic CD4+ T-lymphocytopenia in a child with disseminated cryptococcosis.
Ming XU ; Hong SHI ; Xiao-Hui LI ; Min ZHOU ; Sha LI ; Yi WANG ; Cheng XIE ; Ying LIU ; Jinshu LI ; Wei SHEN
Chinese Journal of Pediatrics 2005;43(1):60-61
3.Recipient lymphopenia state enhances the expansion and anti-leukemia effect of leukemia specific cytotoxic T lymphocytes.
Jing-Wei LOU ; Jian-Min YANG ; Li CHEN ; Xin-Yan JIA ; Wei-Ping ZHANG ; Jian-Min WANG
Chinese Journal of Hematology 2005;26(8):465-468
OBJECTIVETo determine the role of recipient lymphopenia state in the expansion and function of leukemia specific cytotoxic T lymphocytes (CTLs).
METHODSC57BL/6 mice were induced to lymphopenia with 6 Gy total body irradiation. Spleen T cells or leukemia specific T cells from EGFP+ transgenic C57BL/6-EGFP mice were adoptively transferred by intravenous injection. The mice were challenged subcutaneously with 1 x 10(6) FBL3 leukemic cells at day 2 after irradiation. The peripheral WBC count, percentage of EGFP+ cells, subsets of T cells and tumor sizes were monitored.
RESULTBoth of the spleen T cell and leukemia specific CTL proliferated efficiently with the percentage of EGFP+ cells of 28. 81% and 42.24%, respectively, after infused into lymphopenic recipients. However, spleen T cells had no anti-leukemia effect regardless of its expansion. In contrast, leukemia specific CTLs showed a more rapid and extensive expansion under the condition of lymphopenia and a enhanced anti-leukemia immunity.
CONCLUSIONTransfusion of leukemia specific CTLs under lymphopenia state could be a feasible strategy to expand leukemia specific CTLs and generate favorable anti-leukemia effect in vivo.
Animals ; Disease Models, Animal ; Female ; Leukemia ; immunology ; Lymphopenia ; immunology ; Mice ; Mice, Inbred C57BL ; T-Lymphocytes, Cytotoxic ; immunology
4.A Case of Pulmonary Cryptococcosis with Non-Small Cell Lung Cancer in Idiopathic CD4+ T-Lymphocytopenia.
In Seon AHN ; Hee Gu KIM ; Jeong Seon RYU ; Lucia KIM ; Seung Min KWAK ; Hong Lyeol LEE ; Yong Hwan YOON ; Jae Hwa CHO
Yonsei Medical Journal 2005;46(1):173-176
Cryptococcus neoformans commonly causes opportunistic infections in immunocompromised patients, especially in patients with AIDS. CD4+ T-lymphocytopenia in AIDS indicates an increased risk of opportunistic infection and a decline in immunological function. Idiopathic CD4 T-lymphocytopenia (ICL) is characterized by depletions in the CD4+ T-cell subsets, without evidence of HIV infection. Immunodeficiency can exist in the absence of laboratory evidence of HIV infection, and T-cell subsets should be evaluated in patients who present with unusual opportunistic infections. We report a case of pulmonary cryptococcosis and lung cancer in a patient with persistently low CD4+ cell counts, without evidence of HIV infection.
Aged
;
CD4 Lymphocyte Count
;
CD4-Positive T-Lymphocytes/*pathology
;
Carcinoma, Non-Small-Cell Lung/*complications/immunology
;
Cryptococcosis/*complications/immunology
;
Humans
;
Lung Neoplasms/*complications/immunology
;
Lymphopenia/*complications/immunology
;
Male
5.Mechanism of augmented anti-tumor immunity in reconstituted lymphopenic mice immunized with melanoma vaccine.
Jun MA ; Yi-li WANG ; Hong-ming HU ; Bernard A FOX ; Lü-sheng SI
Chinese Journal of Oncology 2005;27(12):708-712
OBJECTIVETo explore mechanisms of the augmented anti-tumor immunity observed in reconstituted lymphopenic mice (RLM) receiving melanoma vaccination.
METHODSThe study is to investigate the anti-tumor immunity of tumor vaccination during early immune reconstitution period following irradiation and cyclophosphamide (CY)-induced lymphopenia. Lymphopenic mice were subsequently reconstituted with naive splenocytes from syngeneic mice and immunized with irradiated melanoma cells F10 (irradiation experiment) and GM-CSF-modified D5 melanoma cells (D5-G6) (CY experiment). Controls included normal C57BL/6 mice receiving the corresponding vaccination, un-immunized naive mice and RLM. 8 - 10 days after vaccination, tumor vaccine draining lymph nodes (TVDLN) were harvested and phenotyped by FACS analysis. T cells purified from TVDLN were stimulated with anti-CD3 and anti-TCRbeta and proliferation was assessed by [(3)H]-TdR incorporation and FACS assay was performed for CD69 expression.
RESULTSThe augmented anti-tumor immunity correlated with a significant increase in the percentage of T cells with activation/memory phenotype in the TVDLN of vaccinated RLM, compared to that of the controls. There was also a significant increase in the density of DCs in TVDLNs. The activation threshold of T cells generated from vaccinated RLM was significantly decreased, resulting in markedly enhanced proliferating capability upon anti-CD3 stimulation.
CONCLUSIONThis study suggests that the augmented anti-tumor immunity observed in vaccinated RLM is due to down regulated activation threshold of T cells during lymphopenia-driven T cell proliferation, which may in turn facilitate the breaking down of immune tolerance to weak tumor antigens upon vaccination with tumor cell vaccines.
Animals ; Cancer Vaccines ; administration & dosage ; Cyclophosphamide ; Lymph Nodes ; immunology ; Lymphopenia ; etiology ; immunology ; Male ; Melanoma, Experimental ; immunology ; therapy ; Mice ; Mice, Inbred C57BL ; T-Lymphocytes ; immunology ; Whole-Body Irradiation
6.Effects of Gender on White Blood Cell Populations and Neutrophil-Lymphocyte Ratio Following Gastrectomy in Patients with Stomach Cancer.
Mi Sook GWAK ; Soo Joo CHOI ; Jie Ae KIM ; Justin Sang KO ; Tae Hyeong KIM ; Sang Min LEE ; Jung A PARK ; Myung Hee KIM
Journal of Korean Medical Science 2007;22(Suppl):S104-S108
Alterations of absolute number or percentage of circulating white blood cell (WBC) subsets are associated with psychological and physical stress. Gender effects on the changes of circulating WBC subsets following surgical treatment have not been determined. Therefore, the current study aimed to determine whether circulating neutrophils, lymphocytes and monocytes, and neutrophil-lymphocyte ratio (N/L) are different following major surgery according to the gender. We studied 409 male patients and 212 female patients who underwent total or subtotal gastrectomy due to stomach cancer, from 1 January to 31 December in 2005. The WBC count and percentage of its subsets were obtained from database and N/L was directly calculated from the full blood count preoperatively, immediate postoperatively, and postoperative day 1, 3, 5 in a retrospective manner. Compared to preoperative values, neutrophilia, lymphopenia, monocytopenia, and increased N/L were associated with gastrectomy in all patients. In the comparison study between genders, there were significantly increased proportion of neutrophils, decreased lymphocytes and monocytes, and higher N/L in female patients than in male patients after gastrectomy. These findings indicate that female patients showed more immune-compromised response to gastrectomy than male patients.
Adult
;
Aged
;
Female
;
Gastrectomy/adverse effects
;
Humans
;
Immunocompromised Host
;
Leukocyte Count
;
Lymphopenia/blood/etiology/immunology
;
Male
;
Middle Aged
;
Monocytes
;
Neutrophils
;
Postoperative Complications/etiology/immunology
;
Retrospective Studies
;
Sex Characteristics
;
Stomach Neoplasms/*blood/immunology/*surgery
7.New strategy of cancer immunotherapy: irradiation or chemotherapeutics-induced lymphopenia combined with immune reconstitution and tumor vaccine.
Jun MA ; Yi-li WANG ; Hong-ming HU ; Bernard A FOX ; Lü-sheng SI
Chinese Journal of Oncology 2005;27(8):452-456
OBJECTIVETo test whether vaccination performed during irradiation or chemotherapeutics-induced lymphopenia-driven T cell proliferation could augment the antitumor immunity.
METHODSThe study composed of two parts, investigating the anti-tumor efficacy of performing tumor vaccination during early immune reconstitution period following sublethal total body irradiation and cyclophosphamide (Cy)-induced lymphopenia, respectively. Mice were subsequently reconstituted with naïve splenocytes from syngeneic mice and were named RLM (Reconstituted lymphopenic mice). Immunization/vaccination (F10) and adoptive immunotherapy (D5-G6) were used to explore anti-tumor immune responses in vaccinated irradiation/RLM and vaccinated Cy/RLM, respectively. Both normal C57BL/6 mice and RLM were vaccinated with irradiated, weakly immunogenic F10 melanoma cells and subsequently challenged with F10 cells. In addition, to determine the role of CD4(+) and CD8(+) T cells in the protective anti-tumor immune response, irradiation/RLM were depleted of these subpopulations by administration of the appropriate mAb around challenge. In the second part, adoptive immunotherapy was used to evaluate the anti-tumor immune responses under chemotherapeutics-induced lymphopenic condition. Both normal mice and RLM (Cy-treated) were vaccinated with GM-CSF-modified D5 melanoma cells (D5-G6) and tumor vaccine draining lymph nodes (TVDLN) were harvested 9-10 days later. Effector T cells were generated in vitro from TVDLN cells and adoptively transferred to mice bearing 3-day pre-established pulmonary metastases (D5). Recipient mice were sacrificed 2 weeks later after tumor inoculation and pulmonary metastases were enumerated.
RESULTSSignificantly greater protection was induced in vaccinated irradiation/RLM, compared to vaccinated normal mice (63.2% vs 16.7%). Protective immunity in RLM depended on CD8(+) T cells. Increase in the interval between reconstitution and vaccination significantly decrease the protection. Effector T cells generated from vaccinated Cy-treated RLM demonstrated significantly higher in vivo anti-tumor efficacy over those of vaccinated normal mice.
CONCLUSIONThis study suggests that vaccination of RLM could elicit augmented antitumor immunity compared to normal hosts, highlighting the potential clinical benefit of performing tumor vaccination during irradiation or chemotherapeutics-induced lymphopenia in cancer patients.
Animals ; CD8-Positive T-Lymphocytes ; immunology ; Cancer Vaccines ; therapeutic use ; Cyclophosphamide ; adverse effects ; Female ; Granulocyte-Macrophage Colony-Stimulating Factor ; immunology ; Immunotherapy, Adoptive ; methods ; Lymphopenia ; etiology ; therapy ; Melanoma, Experimental ; drug therapy ; immunology ; radiotherapy ; Mice ; Mice, Inbred C57BL ; Whole-Body Irradiation
8.Adult T cell leukemia/lymphoma with lymphopenia in a Korean.
Ho Jong JEON ; Mi Ja LEE ; Yu Kyung JEONG ; Dong Myung LEE ; Yoon Kyung OH ; Chul Woo KIM
Journal of Korean Medical Science 2000;15(2):233-239
We experienced a case of adult T cell leukemia/lymphoma (ATLL) in a 48-year-old Korean female, who has never been abroad since birth and no history of blood transfusion. The patient had hypercalcemia and multiple lymphadenopathy. Histopathologic study of left cervical lymph node (LN) and bone marrow (BM) revealed that infiltrates of malignant lymphoid cells were composed of small, medium and large cells with pleomorphic nuclei. Smears of peripheral blood (PB) showed lymphopenia (16%) with the appearance of a few atypical lymphoid cells (less than 2%), but not the typical clover leaf cells seen in ATLL. Immunophenotypic study of LN and BM revealed T cell phenotype. PB showed increased CD4+ T cell (T(H), CD3/CD4+, 57%) and decreased CD8+ T cell counts (T(S), CD3/CD8+, 6.7%). The sera of the patient and her family were reactive for HTLV-I antibody. The specific sequences of pol, env, and tax of HTLV-I DNA were detected in the lymphoma cells and peripheral blood mononuclear cells (PBMC) using polymerase chain reaction. Ultrastructural examination of PBMC confirmed numerous type c virus particles in extracellular space. This case was an acute type of ATLL without overt leukemic features in PB. Despite chemotherapy and intensive conservative treatment, she died 3 months after admission.
Biopsy
;
Bone Marrow/pathology
;
Case Report
;
DNA, Viral/analysis
;
Fatal Outcome
;
Female
;
Flow Cytometry
;
Gene Products, env/genetics
;
Gene Products, pol/genetics
;
Gene Products, tax/genetics
;
HTLV-BLV Infections/pathology
;
HTLV-I
;
Human
;
Hypercalcemia/virology
;
Hypercalcemia/pathology
;
Immunophenotyping
;
Korea
;
Leukemia, T-Cell/virology
;
Leukemia, T-Cell/pathology*
;
Leukemia, T-Cell/immunology
;
Lymph Nodes/pathology
;
Lymphopenia/virology
;
Lymphopenia/pathology*
;
Lymphopenia/immunology
;
Microscopy, Electron
;
Middle Age
;
Support, Non-U.S. Gov't
;
T-Lymphocytes/virology
;
T-Lymphocytes/ultrastructure
;
T-Lymphocytes/pathology
9.Research progress of peripheral blood count test in the evaluation of prognosis of gastric cancer.
Chinese Journal of Gastrointestinal Surgery 2017;20(2):236-240
Gastric cancer (GC) is one of the most common tumor in the world, and remains a major public health problem and one of the leading causes of death. Recently many researches have demonstrated that systemic inflammatory response is associated with prognosis and response to therapy in gastric cancer, and the peripheral blood count test can partly reflect the systemic inflammatory response. Based on the peripheral blood count test, there are a lot of research regarding the relation between the platelet count (PLT), neutrophil, lymphocyte, white blood cell (WBC), neutrophil to lymphocyte ratio(NLR), platelet to lymphocyte ratio (PLR) with their prognostic role in gastric cancer. A high PLT and preoperative lymphocytopenia are both associated with increased lymph node metastasis, stage (III(+IIII(), serosal invasion (T3+T4) risk and poorer overall survival. Besides above, platelet monitoring following surgery can be applied to predict the recurrence for patients with GC that suffer preoperative high PLT but have restored PLT levels following resection. Moreover systemic inflammatory factors based on blood parameters, such as PLR, NLR and so on, have relation with the poor prognosis of patients with GC. Among them, high NLR is a negative predictor of prognosis in GC patients. However PLR remains inconsistent, while most researches demonstrated high PLR may be useful prognostic factor rather than independent prognostic factor. There are still some limitations which include various cut-off values, little of clinician attention, the uncertain mechanism, etc. Here we review the research progress in the prognostic role of the blood count test in gastric cancer.
Blood Cell Count
;
methods
;
statistics & numerical data
;
Blood Platelets
;
physiology
;
Humans
;
Inflammation
;
blood
;
diagnosis
;
immunology
;
Leukocyte Count
;
statistics & numerical data
;
Lymphatic Metastasis
;
diagnosis
;
immunology
;
Lymphocyte Count
;
statistics & numerical data
;
Lymphopenia
;
blood
;
physiopathology
;
Neoplasm Invasiveness
;
immunology
;
Neoplasm Recurrence, Local
;
blood
;
diagnosis
;
Neoplasm Staging
;
statistics & numerical data
;
Neutrophils
;
immunology
;
Platelet Count
;
statistics & numerical data
;
Prognosis
;
Stomach Neoplasms
;
blood
;
diagnosis
;
immunology
;
mortality
;
Treatment Outcome
10.Predictors associated with clinical deterioration in SARS patients.
Jie YAN ; Xin FENG ; Jing-hua TIAN ; Yao XIE ; Jun YAO ; Zhong-ping HE ; Dao-zhen XU
Chinese Journal of Experimental and Clinical Virology 2003;17(3):222-224
BACKGROUNDTo study the predictive factors associated with clinical deterioration in SARS patients.
METHODSThe clinical data of 60 SARS patients were analyzed by logistic regression and Cox's proportional hazards analysis.
RESULTSIn logistic regression models, both older age (P=0.009) and severe lymphopenia (P=0.004) were significant predictors of clinical deterioration. In Cox's proportional hazard models, severe lymphopenia was significant predictor associated with prolongation of stay in hospital.
CONCLUSIONOlder age and severe lymphopenia seem to be statistically significant for predicting the clinical deterioration in SARS patients.
Adult ; Aged ; Disease Progression ; Female ; Humans ; Logistic Models ; Lymphopenia ; virology ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Proportional Hazards Models ; Random Allocation ; SARS Virus ; Severe Acute Respiratory Syndrome ; complications ; diagnosis ; immunology ; virology